Latest News
Akiko Iwasaki, Yale professor of immunobiology and WHRY collaborator, is the co-author of a review article on Covid-19 related cognitive impairment. The condition has affected people with cancer and other chronic conditions for years, but long Covid is just beginning to push it into the spotlight.
- November 22, 2022Source: WTNH News 8
The Yale School of Medicine played a major role in the introduction of a drug that aims to improve the lives of people with diabetes.
- November 18, 2022
Teplizumab can change the course of type 1 diabetes, one of the most common chronic diseases of childhood, and the lives of those who might develop the disease.
- November 18, 2022Source: The New York Times
The therapy will cost nearly $200,000. But it’s the first treatment in 100 years to alter the course of the disease, which usually begins in adolescence.
- November 18, 2022Source: New Scientist
A new kind of therapy that could delay the start of type 1 diabetes in children by up to three years has been approved for use in the US.
- November 17, 2022
Discoveries & Impact highlights select scientific discoveries per section across the Department of Internal Medicine...
- November 10, 2022
Applications are being accepted for pilot and feasibility project grants from the Yale Diabetes Research Center (DRC). The grants will provide seed money for investigators to explore the feasibility of diabetes or metabolism-related studies and to obtain sufficient data to further pursue such lines of investigation via other funding mechanisms.
- November 09, 2022Source: ctinsider
Inflammation is the general term for the increased activity of the immune system cells and other cells.
- November 07, 2022
As part of our “Meet Yale Internal Medicine” series, we are featuring Benjamin Goldman-Israelow, MD, PhD, assistant professor in medicine and former ABIM Physician-Scientist Research Pathway Resident.
- November 05, 2022Source: News 8
It's important to get the COVID-19 and flu vaccinations as the winter holidays approach.